Evidence map›Paper›PMID 20807776›Full record

ArticleHuman molecular genetics2010

A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons.

Kerstin E Braunstein, Judith Eschbach, Krisztina Ròna-Vörös, Rana Soylu, Elli Mikrouli, Yves Larmet, Frédérique René, Jose-Luis Gonzalez De Aguilar, Jean-Philippe Loeffler, Hans-Peter Müller and 12 more

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in neural circuits · 2019
    Article
  6. IKK2/NF-κB signaling protects neurons after traumatic brain injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Kerstin E BraunsteinDepartment of Neurology, University of Ulm, Ulm, Germany.
Judith Eschbach
Krisztina Ròna-Vörös
Rana Soylu
Elli Mikrouli
Yves Larmet
Frédérique René
Jose-Luis Gonzalez De Aguilar
Jean-Philippe Loeffler
Hans-Peter Müller
Selina Bucher
Thomas Kaulisch
Heiko G Niessen
Julia Tillmanns
Kristina Fischer
Birgit Schwalenstöcker
Jan Kassubek
Bernd Pichler
Detlef Stiller
Asa Petersen
Albert C Ludolph
Luc Dupuis
Universität Ulm · DEBoehringer Ingelheim (Germany) · DEInserm · FRLund University · SEMécanismes Centraux et Périphériques de la Neurodégénérescence · FRUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular motor dynein and its associated regulatory subunit dynactin have been implicated in several neurodegenerative conditions of the basal ganglia, such as Huntington's disease (HD) and Perry syndrome, an atypical Parkinson-like disease. This pathogenic role has been largely postulated from the existence of mutations in the dynactin subunit p150(Glued). However, dynactin is also able to act independently of dynein, and there is currently no direct evidence linking dynein to basal ganglia degeneration. To provide such evidence, we used here a mouse strain carrying a point mutation in the dynein heavy chain gene that impairs retrograde axonal transport. These mice exhibited motor and behavioural abnormalities including hindlimb clasping, early muscle weakness, incoordination and hyperactivity. In vivo brain imaging using magnetic resonance imaging showed striatal atrophy and lateral ventricle enlargement. In the striatum, altered dopamine signalling, decreased dopamine D1 and D2 receptor binding in positron emission tomography SCAN and prominent astrocytosis were observed, although there was no neuronal loss either in the striatum or substantia nigra. In vitro, dynein mutant striatal neurons displayed strongly impaired neuritic morphology. Altogether, these findings provide a direct genetic evidence for the requirement of dynein for the morphology and function of striatal neurons. Our study supports a role for dynein dysfunction in the pathogenesis of neurodegenerative disorders of the basal ganglia, such as Perry syndrome and HD.

Indexed as

Point MutationAnimalsAtrophyBehavior, AnimalCells, CulturedCorpus StriatumDopamineDynactin ComplexDyneinsEmbryo, MammalianHeterozygoteHuntington DiseaseMaleMiceMice, Inbred C3HMicrotubule-Associated ProteinsDctn1 protein, mouseDopamineDynactin ComplexDyneinsMicrotubule-Associated ProteinsReceptors, Dopamine D2

Identifiers

PMID20807776
PMCPMC3298848
OpenAlexW2123202217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.